No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2173759 |
chr5:17404483-17404484 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs535814417 |
chr5:17404517-17404518 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs542064277 |
chr5:17404518-17404519 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs73054890 |
chr5:17404531-17404532 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs2036339 |
chr5:17404549-17404550 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs138959115 |
chr5:17404596-17404597 |
Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs557926210 |
chr5:17404618-17404619 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs577854657 |
chr5:17404633-17404634 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs543689323 |
chr5:17404639-17404640 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs376083905 |
chr5:17404721-17404722 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs564036451 |
chr5:17404725-17404726 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs557152891 |
chr5:17404796-17404797 |
Bivalent Enhancer Enhancers Weak transcription Active TSS Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs112879720 |
chr5:17404836-17404837 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs185811872 |
chr5:17404839-17404840 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs575524622 |
chr5:17404885-17404886 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs566534263 |
chr5:17404903-17404904 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs561533059 |
chr5:17404908-17404909 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs191556557 |
chr5:17404959-17404960 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs182989274 |
chr5:17404975-17404976 |
Enhancers Weak transcription Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs73054891 |
chr5:17405078-17405079 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs571538576 |
chr5:17405107-17405108 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs187660133 |
chr5:17405165-17405166 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs533888046 |
chr5:17405181-17405182 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs192193304 |
chr5:17405340-17405341 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs371545629 |
chr5:17405367-17405368 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs561210924 |
chr5:17405388-17405389 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs142877965 |
chr5:17405471-17405472 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs57052312 |
chr5:17405511-17405512 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs555685771 |
chr5:17405546-17405547 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs575504241 |
chr5:17405567-17405568 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs545941962 |
chr5:17405570-17405571 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs73756179 |
chr5:17405582-17405583 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs567342008 |
chr5:17405593-17405594 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs547142137 |
chr5:17405602-17405603 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs66514722 |
chr5:17405638-17405639 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs534782656 |
chr5:17405639-17405640 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs398064591 |
chr5:17405652-17405653 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs557861838 |
chr5:17405679-17405680 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs80325795 |
chr5:17405741-17405742 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs543579431 |
chr5:17405744-17405745 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs12653746 |
chr5:17405768-17405769 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs574230846 |
chr5:17405792-17405793 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs150776898 |
chr5:17405803-17405804 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs17658678 |
chr5:17405816-17405817 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs550280345 |
chr5:17405895-17405896 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs138008630 |
chr5:17405924-17405925 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs2454945 |
chr5:17405925-17405926 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs151125255 |
chr5:17405939-17405940 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs149485640 |
chr5:17405970-17405971 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs77493377 |
chr5:17405980-17405981 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|